Target Healthcare REIT (LON:THRL – Get Free Report)’s stock price passed below its fifty day moving average during trading on Thursday . The stock has a fifty day moving average of GBX 104.93 and traded as low as GBX 104.39. Target Healthcare REIT shares last traded at GBX 104.60, with a volume of 821,782 shares trading hands.
Analyst Ratings Changes
Separately, Jefferies Financial Group restated a “hold” rating and issued a GBX 101 price target on shares of Target Healthcare REIT in a research note on Wednesday, May 6th. One analyst has rated the stock with a Hold rating, According to data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus target price of GBX 101.
Read Our Latest Report on THRL
Target Healthcare REIT Price Performance
Target Healthcare REIT (LON:THRL – Get Free Report) last issued its quarterly earnings data on Wednesday, March 18th. The company reported GBX 3.38 earnings per share (EPS) for the quarter. Target Healthcare REIT had a return on equity of 10.73% and a net margin of 104.45%. On average, research analysts predict that Target Healthcare REIT will post 6.2219101 earnings per share for the current fiscal year.
About Target Healthcare REIT
Our investment objective is to provide shareholders with an attractive level of income together with the potential for capital and income growth, from a portfolio of UK care homes, diversified by tenant, geography, and resident payment profile. We only invest in modern, purpose-built homes.
See Also
- Five stocks we like better than Target Healthcare REIT
- The Great AI Server Rotation Puts Hewlett Packard Enterprise and Super Micro Computer in Focus
- Generac’s AI Power Pivot Raises a Bigger Question About Data Center Demand
- Medtronic Bottoms, Healthy Rebound Ahead
- GitLab’s Price Recovery Gains Traction—Time to Get On Board?
Receive News & Ratings for Target Healthcare REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Target Healthcare REIT and related companies with MarketBeat.com's FREE daily email newsletter.
